Literature DB >> 4091525

Inoculum effect of beta-lactam antibiotics on Enterobacteriaceae.

R H Eng, C Cherubin, S M Smith, F Buccini.   

Abstract

Seven beta-lactam antibiotics were studied for both their antimicrobial activity and the degree to which they produced inoculum effect on Escherichia coli, Klebsiella pneumoniae, and Salmonella typhimurium. Aztreonam, cefoperazone, and ceftazidime were poorly bactericidal, caused marked bacterial filamentation, and exhibited a large inoculum effect on E. coli, K. pneumoniae, and S. typhimurium. Cefotaxime and ceftriaxone were more rapidly bactericidal, caused only a moderate amount of filamentous forms, and exhibited a modest inoculum effect, while cefoxitin and imipenem both were rapidly bactericidal and exhibited only a minimal-to-no-inoculum effect. The inoculum effect did not correlate with drug stability during incubation with the bacteria. Inoculum effect on these species of the family Enterobacteriaceae appears to be a manifestation of increase in optical density secondary to the development of filamentous bacterial forms with an increase in bacterial mass during exposure to antibiotics which are not rapidly bactericidal. These observations have a clear significance for the susceptibility testing of beta-lactam antibiotics when turbidity is used as a parameter to determine presence of bacterial growth.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4091525      PMCID: PMC176342          DOI: 10.1128/AAC.28.5.601

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins.

Authors:  L D Sabath; C Garner; C Wilcox; M Finland
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

2.  Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation.

Authors:  S W Chapman; R T Steigbigel
Journal:  J Infect Dis       Date:  1983-06       Impact factor: 5.226

3.  Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa.

Authors:  R H Eng; S M Smith; C Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

4.  Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species.

Authors:  R R Bulger; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

5.  Comparative in vitro study in new cephalosporins.

Authors:  G P Bodey; V Fainstein; A M Hinkle
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

6.  Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.

Authors:  M L Corrado; S H Landesman; C E Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

7.  Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.

Authors:  M N Gwynn; G N Rolinson
Journal:  Infection       Date:  1980       Impact factor: 3.553

  7 in total
  16 in total

1.  In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates.

Authors:  J Kohler; K L Dorso; K Young; G G Hammond; H Rosen; H Kropp; L L Silver
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  The controlled in vitro susceptibility of gastrointestinal pathogens to the antibacterial effect of manuka honey.

Authors:  S M Lin; P C Molan; R T Cursons
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-17       Impact factor: 3.267

3.  Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations.

Authors:  E J Goldstein; D M Citron; C E Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

4.  Inoculum effect of β-lactam antibiotics.

Authors:  Justin R Lenhard; Zackery P Bulman
Journal:  J Antimicrob Chemother       Date:  2019-10-01       Impact factor: 5.790

5.  Method of evaluating effects of antibiotics on bacterial biofilm.

Authors:  B L Prosser; D Taylor; B A Dix; R Cleeland
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

6.  In vivo significance of the inoculum effect of antibiotics on Escherichia coli.

Authors:  F Soriano; M Santamaría; C Ponte; C Castilla; R Fernández-Roblas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

7.  Effect of pathological changes of pH, pO2 and pCO2 on the activity of antimicrobial agents in vitro.

Authors:  C König; H P Simmen; J Blaser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-07       Impact factor: 3.267

8.  Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa.

Authors:  Jürgen B Bulitta; Neang S Ly; Jenny C Yang; Alan Forrest; William J Jusko; Brian T Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2008-10-13       Impact factor: 5.191

9.  Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group.

Authors:  E J Goldstein; D M Citron; C E Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

10.  Evaluation of ceftriaxone and other antibiotics against Escherichia coli, Pseudomonas aeruginosa, and Streptococcus pneumoniae under in vitro conditions simulating those of serious infections.

Authors:  G Satta; G Cornaglia; G Foddis; R Pompei
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.